Dopamine Agonists in Type 2 Diabetes

Erscheinungsjahr 2011
ISBN: 978-0-19-977351-0
Verlag: Oxford University Press

Buch, Englisch, Gewicht: 10 g

Reihe: Oxford American Pocket Cards

Diabetes is the most prevalent metabolic disorder in the world. With many types of therapies available, including the mainstay insulin, the disease is manageable in most people. However, current anti-diabetes medications act primarily on peripheral end organs to regulate glucose and insulin levels. Dopamine agonist therapy, which targets the neuroendocrine patterns associated with insulin resistance, is a novel approach for diabetes treatment. Part of the Oxford American
Pocket Cards series, this portable, ultra-concise and up-to-date brochure provides key clinical insight as well as dosing and administration guidelines for newly FDA-approved dopamine agonist therapy for Type 2 diabetes.

To purchase this product, please contact U.S. Medical Sales at [e-mail]

Autoren/Hrsg.

Fonseca, Vivian

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Endokrinologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Diabetologie

Über Autor(innen)

Vivian Fonseca, Tullis-Tulane Alumni Chair in Diabetes, Tulane University School of Medicine, USA

Vivian Fonseca Tullis-Tulane Alumni Chair in Diabetes Professor of Medicine Chief, Section of Endocrinology Tulane University School of Medicine New Orleans, LA